Clinical Trial Update: Prevention of Diarrheal Disease Due to Infection With Enterotoxigenic E. Coli (ETEC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating prevention of diarrheal disease caused by enterotoxigenic E. coli (ETEC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Snippet

Sponsor: Scandinavian Biopharma AB | Conditions: Diarrhea | Phase 2 | Status: COMPLETED